Tech
|
Updated on 03 Nov 2025, 04:46 pm
Reviewed By
Aditi Singh | Whalesbook News Team
▶
Hospitality technology firm OYO has decided to withdraw its existing bonus resolution plan, opting instead to introduce a new, unified structure for all its shareholders. This decision comes after the company received feedback from investors regarding the initial proposal.
The original plan had distinct categories for investors. Those who did not respond to the postal ballot were to be classified under ‘Class A’, receiving one bonus compulsory convertible preference share (CCPS) for every 6,000 equity shares held. Investors who actively opted in within the designated election window could choose ‘Class B’, where the conversion of one CCPS into equity shares was contingent on OYO appointing merchant bankers for its IPO before March 2026.
Following initial feedback, OYO's parent PRISM extended the opt-in window. However, the company has now chosen to roll back the plan entirely. The new proposal will be a single, comprehensive structure applicable to all classes of shareholders, irrespective of their holding size, and will not necessitate any application process.
A company spokesperson stated, “We are not proceeding with the current resolution and will shortly bring a fresh, unified proposal for shareholder approval.” This action is highlighted as a reflection of OYO's commitment to governance-first growth and fairness.
Impact: This change demonstrates OYO's responsiveness to shareholder concerns, which could boost investor confidence. The simplification of the bonus structure might improve its appeal. However, the need to re-propose a plan could introduce minor delays in OYO's broader corporate actions, including potential IPO preparations. Rating: 5/10.
Difficult terms: Bonus resolution plan: A plan detailing the distribution of bonus shares or other benefits to shareholders. Shareholder feedback: Opinions and suggestions provided by individuals who own shares in a company. Postal ballot: A method for shareholders to cast their vote on company matters by mail. Compulsorily convertible preference share (CCPS): A type of preference share that must be converted into equity shares under specific conditions. Equity shares: The basic form of stock representing ownership in a company. IPO (Initial Public Offering): The process by which a private company first offers its shares to the public. Merchant bankers: Financial institutions that advise companies on issuing new securities and managing IPOs. PRISM: The parent entity of OYO. Unified proposal: A single plan designed to apply universally to all relevant parties.
Tech
India's R&D push: PM Modi inaugrates ESTIC; launches Rs 1 lakh-crore fund to boost private investment
Tech
Connected devices may face mandatory security checks before you can use them
Tech
Mint explainer: What Swiggy and Zomato’s spending patterns reveal about their future
Tech
TCS says $6.5 bn data-centre bet will lag IT business on profitability
Tech
Exclusive: Amazon To Cut 2,000 Jobs In India In Restructuring Drive
Tech
TBO Tek Q2: Profit Rises 13% YoY To INR 68 Cr
Brokerage Reports
Groww = Angel One+ IIFL Capital + Nuvama. Should you bid?
Energy
How India’s quest to build a global energy co was shattered
Banking/Finance
KKR Global bullish on India; eyes private credit and real estate for next phase of growth
Industrial Goods/Services
NHAI monetisation plans in fast lane with new offerings
Transportation
You may get to cancel air tickets for free within 48 hours of booking
Media and Entertainment
Guts, glory & afterglow of the Women's World Cup: It's her story and brands will let her tell it
Startups/VC
SC Dismisses BYJU’S Plea To Halt Aakash’s Rights Issue
Startups/VC
Info Edge To Infuse INR 100 Cr In Investment Arm Redstart Labs
Startups/VC
Profit paradox: What’s distorting IPO valuations? Zerodha’s Nithin Kamath shares striking insights
Healthcare/Biotech
FlynnCare Health Innovations wins silver for AI-powered preventive health platform
Healthcare/Biotech
Fatal neglect
Healthcare/Biotech
Ajanta Pharma Q2: Profit rises 20%, revenue grows; interim dividend declared
Healthcare/Biotech
What’s powering Mounjaro’s rise to the top of Indian drug market
Healthcare/Biotech
Cipla to acquire 100% stake in Inzpera Healthsciences for ₹111 crore
Healthcare/Biotech
Wockhardt Q2 Results: Stock surges after drugmaker reports net profit from loss last year